![Daniel Swisher](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Patrimonio netto: 447 017 $ in data 31/05/2026
Daniel N. Swisher è presidente e direttore operativo di Jazz Pharmaceuticals Plc, presidente e direttore operativo di Jazz Pharmaceuticals, Inc., direttore indipendente di Corcept Therapeutics, Inc. e presidente di Cerus Corp. Fa parte del Consiglio di amministrazione di Corcept Therapeutics, Inc. Swisher è stato precedentemente impiegato come presidente, amministratore delegato, segretario e direttore di Sunesis Pharmaceuticals, Inc. e vicepresidente senior delle vendite e del marketing di ALZA Corp. Si è laureato alla Yale University e ha conseguito un MBA alla Stanford Graduate School of Business.
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
CERUS CORPORATION 0,07% | 03/06/2025 | 147.045 ( 0,07% ) | 447 017 $ | 31/05/2026 |
| 21/05/2026 | 0 ( -.--% ) | - $ | 31/05/2026 |
| Società | Posizione | Inizio |
|---|---|---|
| CORCEPT THERAPEUTICS INCORPORATED | Direttore/Membro del Consiglio | 18/06/2015 |
| Società | Posizione | Fine |
|---|---|---|
NodThera Ltd.
 NodThera Ltd. BiotechnologyHealth Technology Operates biotechnology company which discovers and develops new treatments for diseases driven by chronic inflammation | Amministratore Delegato | 04/02/2026 |
| CERUS CORPORATION | Presidente | 16/06/2025 |
| PROTAGONIST THERAPEUTICS, INC. | Direttore/Membro del Consiglio | 17/09/2024 |
| JAZZ PHARMACEUTICALS PLC | Presidente | 01/10/2023 |
| VIRACTA THERAPEUTICS, INC. | Amministratore Delegato | 31/12/2017 |
Attive
Inattive
Società nel listino
Aziende private
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
| Aziende private | 9 |
|---|---|
ALZA Corp.
 ALZA Corp. Pharmaceuticals: MajorHealth Technology Provides and develops pharmaceutical products | Health Technology |
Cerus Corp.
 Cerus Corp. Medical SpecialtiesHealth Technology Develops and commercializes the INTERCEPT Blood System for platelets and plasma | Health Technology |
Corcept Therapeutics, Inc.
 Corcept Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Engages in discovery and development of drugs which treat severe metabolic, oncologic and neuropsychiatric disorders | Health Technology |
Sunesis Pharmaceuticals, Inc.
 Sunesis Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops oncology therapeutics for treatment of solid and hematologic cancers | Health Technology |
Yale University
 Yale University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Protagonist Therapeutics, Inc.
 Protagonist Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Manufactures peptide based therapeutic products | Health Technology |
Jazz Pharmaceuticals Plc
 Jazz Pharmaceuticals Plc Pharmaceuticals: MajorHealth Technology Engages in the development and commercialization of pharmaceutical products to treat neurological disorders | Health Technology |
Stanford Graduate School of Business
 Stanford Graduate School of Business Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
NodThera Ltd.
NodThera Ltd. BiotechnologyHealth Technology Operates biotechnology company which discovers and develops new treatments for diseases driven by chronic inflammation | Health Technology |
Seleziona la tua edizione
Tutte le informazioni finanziarie adattate in base al livello nazionale
